Published in J BUON on July 28, 2015
Rituximab-related viral infections in lymphoma patients. Leuk Lymphoma (2007) 2.55
Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates. J Bone Miner Res (2008) 2.42
Sonographic and electrodiagnostic evaluations in patients with aromatase inhibitor-related arthralgia. J Clin Oncol (2009) 1.60
Variation in hormone receptor and HER-2 status between primary and metastatic breast cancer: review of the literature. Expert Opin Ther Targets (2010) 1.48
Calcium and vitamin D supplementation during bisphosphonate administration may increase osteoclastic activity in patients with bone metastasis. Med Hypotheses (2004) 1.42
Liver toxicity due to broccoli juice. Eur J Gastroenterol Hepatol (2010) 1.39
Manipulating the chemokine-chemokine receptor network to treat cancer. Cancer (2007) 1.38
Value of preoperative ultrasound-guided axillary lymph node biopsy for preventing completion axillary lymph node dissection in breast cancer: a systematic review and meta-analysis. Ann Surg Oncol (2013) 1.36
Metaplastic breast carcinoma: case series and review of the literature. Asian Pac J Cancer Prev (2012) 1.18
Comparative study of the immunohistochemical detection of hormone receptor status and HER-2 expression in primary and paired recurrent/metastatic lesions of patients with breast cancer. Med Oncol (2010) 1.16
Cytomegalovirus gastritis after rituximab treatment in a non-Hodgkn's lymphoma patient. World J Gastroenterol (2006) 1.10
EGFR expression and gene copy number in triple-negative breast carcinoma. Cancer Genet Cytogenet (2010) 1.08
Association between common risk factors and molecular subtypes in breast cancer patients. Breast (2012) 1.06
Unusual location of hydatid cyst: soft tissue mass in the neck. Eur Arch Otorhinolaryngol (2006) 1.01
Why osteonecrosis of the jaw after bisphosphonates treatment is more frequent in multiple myeloma than in solid tumors. J Oral Maxillofac Surg (2006) 1.00
Serum lactate dehydrogenase level is a prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy. Cancer Invest (2007) 1.00
Outcome of non-metastatic male breast cancer: 118 patients. Med Oncol (2011) 0.99
Metastatic granular cell tumor: a case report and review of the literature. Acta Oncol (2006) 0.97
Cardiotoxicity of novel HER2-targeted therapies. Curr Med Res Opin (2013) 0.97
From endometrial hyperplasia to endometrial cancer: insight into the biology and possible medical preventive measures. Eur J Cancer Prev (2008) 0.96
Clinical utility of ultrasound-needle biopsy for preoperative staging of the axilla in invasive breast cancer. Anticancer Res (2014) 0.95
Stem cell-related markers in primary breast cancers and associated metastatic lesions. Mod Pathol (2012) 0.95
Systemic treatment in breast-cancer patients with brain metastasis. Expert Opin Pharmacother (2010) 0.95
Pertuzumab in HER2-positive breast cancer. Curr Med Res Opin (2012) 0.94
Could the hand-foot syndrome after capecitabine treatment be associated with better outcome in metastatic breast cancer patients? Acta Oncol (2006) 0.94
Probable sorafenib-induced reversible encephalopathy in a patient with hepatocellular carcinoma. Med Oncol (2010) 0.94
Trastuzumab emtansine (T-DM1) for HER2-positive breast cancer. Curr Med Res Opin (2013) 0.93
Metaplastic breast carcinoma: a heterogeneous disease. Asian Pac J Cancer Prev (2014) 0.92
Breast cancer subtypes and outcomes of central nervous system metastases. Breast (2011) 0.92
Zoledronic acid and atrial fibrillation in cancer patients. Support Care Cancer (2010) 0.92
CD40 signaling predicts response to preoperative trastuzumab and concomitant paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide in HER-2-overexpressing breast cancer. Breast Cancer Res (2007) 0.91
Hormone receptor status in patients with breast cancer and liver metastases treated with laser-induced intersititial thermotherapy. Radiology (2005) 0.91
Anterior abdominal wall synovial sarcoma: a rare presentation. Am J Clin Oncol (2005) 0.91
Warfarin-induced skin necrosis and leukocytoclastic vasculitis in a patient with acquired protein C and protein S deficiency. Blood Coagul Fibrinolysis (2007) 0.90
Characteristics of breast cancer patients with central nervous system metastases: a single-center experience. J Natl Med Assoc (2008) 0.90
Brain metastasis of cardiac myxoma: case report and review of the literature. J Neurooncol (2005) 0.90
Addition of rituximab to chop does not increase the risk of cardiotoxicity in patients with non-Hodgkin's lymphoma. Med Oncol (2008) 0.90
Bone metastasis from gastric cancer: the incidence, clinicopathological features, and influence on survival. J Gastric Cancer (2014) 0.90
Possible association between nanobacteria and malignant microcalcifications in breast cancer. Breast J (2006) 0.89
Orbital metastasis from adenocarcinoma of the colon. South Med J (2005) 0.88
Trastuzumab in metastatic breast cancer after complete remission: How long is enough? Med Oncol (2015) 0.88
Demographic and clinico-pathological characteristics in patients with triple-negative and non-triple-negative breast cancer. Med Oncol (2010) 0.88
Results of adjuvant FOLFOX regimens in stage III colorectal cancer patients: retrospective analysis of 667 patients. Oncology (2013) 0.87
Optimal timing of adjuvant treatment in patients with early breast cancer. Med Oncol (2010) 0.87
Cutaneous metastases of signet cell carcinoma of the rectum without accompanying visceral involvement. South Med J (2006) 0.87
Serum leptin, resistin and TNF-α levels in patients with systemic sclerosis: the role of adipokines in scleroderma. Int J Rheum Dis (2012) 0.87
Demographic and clinico-pathological characteristics in patients with invasive breast cancer receiving metformin. Med Oncol (2013) 0.86
Ductal carcinoma in situ and bilateral atypical ductal hyperplasia in a 23-year-old man with gynecomastia. Am Surg (2011) 0.86
Outcomes of locally advanced breast cancer patients with ≥ 10 positive axillary lymph nodes. Med Oncol (2013) 0.86
Treatment and outcomes of Ewing sarcoma in Turkish adults: a single centre experience. Asian Pac J Cancer Prev (2014) 0.86
Doxorubicin-induced second degree and complete atrioventricular block. Europace (2005) 0.86
Angiotensin-converting enzyme inhibitors for bevacizumab-induced hypertension. Ann Pharmacother (2006) 0.85
Leptin and breast cancer: an overview. Med Oncol (2011) 0.84
Pentoxifylline and alpha-tocopherol in prevention of radiation-induced lung toxicity in patients with lung cancer. Med Oncol (2007) 0.84
Blood ABO groups and risk of breast cancer. Med Oncol (2010) 0.84
Herpes simplex type-2 encephalitis masked by diabetic ketoacidosis. J Natl Med Assoc (2005) 0.84
Impact of inflammatory markers on the prognosis of patients with operable breast cancer. J BUON (2014) 0.84
Demographic and clinico-pathological characteristics of breast cancer patients with history of oral alendronate use. Med Oncol (2012) 0.84
Preoperative Doppler sonography for prevention of perioperative stroke in head and neck cancer patients undergoing neck dissection: is it beneficial? J Clin Ultrasound (2007) 0.84
Common etiology of capecitabine and fluorouracil-induced coronary vasospasm in a colon cancer patient. Ann Pharmacother (2005) 0.84
The role of aromatase inhibitors in the adjuvant treatment of breast carcinoma: the M. D. Anderson Cancer Center evidence-based approach. Cancer (2004) 0.84
Treatment of recurrent cerebellar hemangioblastoma with external radiotherapy in a patient with von Hippel-Lindau disease: a case report and review of the literature. J Neurooncol (2005) 0.84
Low ERCC1 expression is associated with prolonged survival in patients with bladder cancer receiving platinum-based neoadjuvant chemotherapy. Urol Oncol (2012) 0.83
Pharmacotherapy of triple-negative breast cancer. Expert Opin Pharmacother (2009) 0.83
Isolated granulocytic sarcoma of the head and neck preceding acute myeloid leukemia. Am J Hematol (2004) 0.83
Interleukin-6 and C-reactive protein in metastatic renal cell carcinoma. J Clin Oncol (2005) 0.83
Emerging drugs in metastatic breast cancer. Expert Opin Emerg Drugs (2009) 0.82
Liver dysfunction after chemotherapy in lymphoma patients infected with hepatitis C. Eur J Haematol (2008) 0.82
Clinical characteristics and outcome of patients with stage III esophageal carcinoma: a single-center experience from Turkey. Med Oncol (2007) 0.82
Renal safety of zoledronic acid administration beyond 24 months in breast cancer patients with bone metastases. Med Oncol (2008) 0.82
The efficacy of adjuvant trastuzumab in HER-2 positive breast cancer with axillary lymph node metastases according to the treatment duration. Curr Med Res Opin (2014) 0.82
Successful treatment of chronic hiccup with baclofen in cancer patients. Med Oncol (2011) 0.81
Urotensin-II in systemic sclerosis: a new peptide in pathogenesis. Clin Rheumatol (2011) 0.81
Extramedullary plasmacytoma of nasopharynx and larynx: synchronous presentation. Am J Hematol (2004) 0.81
Comparison of cisplatin-5-fluorouracil-folinic acid versus modified docetaxel-cisplatin-5-fluorouracil regimens in the first-line treatment of metastatic gastric cancer. Chemotherapy (2011) 0.81